Loading…
Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients
Abstract The role of the Smac/DIABLO protein, a novel apoptosis agonist, in acute myeloid leukemia (AML) is not clearly determined. The expression of Smac/DIABLO protein in AML leukemic cells and its relationship with clinical outcome was evaluated in this study. The intracellular expression of Smac...
Saved in:
Published in: | Leukemia research 2010-10, Vol.34 (10), p.1308-1313 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract The role of the Smac/DIABLO protein, a novel apoptosis agonist, in acute myeloid leukemia (AML) is not clearly determined. The expression of Smac/DIABLO protein in AML leukemic cells and its relationship with clinical outcome was evaluated in this study. The intracellular expression of Smac/DIABLO protein was assessed using multi-color flow cytometry in 71 newly diagnosed AML patients treated with conventional chemotherapy. It was found that the high expression of Smac/DIABLO protein was an independent prognostic factor in terms of higher complete remission rate ( p < 0.001) and longer overall survival ( p = 0.003). Moreover the low expression of Smac/DIABLO protein was associated with poor karyotype. |
---|---|
ISSN: | 0145-2126 1873-5835 |
DOI: | 10.1016/j.leukres.2009.11.030 |